prescribe Dexcom G7: the most accurate CGM system1 for confident diabetes management
From the #1 recommended continuous glucose monitoring brand2,3
Smart device sold separately.*
THE MOST ACCURATE CGM SYSTEM1 JUST GOT BETTER.
Direct to Apple Watch*
Your patients can connect their sensor directly to their Apple Watch* so they can leave their iPhone behind†and still see their glucose numbers.
Enhanced event logging‡
Automated activity logging, simplified meal logging, and new medication logging help your patients better understand how activity, food, and medications impact their glucose in real time, so it's easier to make informed decisions and gain more control.
Enhanced Bluetooth with Rapid Reconnect
The Dexcom G7 sensor now has enhanced Bluetooth with Rapid Reconnect. It delivers a 65% farther§,4 range and a quicker reconnection when your patients go out of range, keeping them connected longer so they have less time without their numbers.
the most accurate CGM system1
For reliable treatment decisions that lead to proven results5-9
Smart device sold separately.*
the simple CGM system
For effortless diabetes management that leads to better adherence12
2x faster warmup than FreeStyle Libre4,10 for easy setup and a quick start for you and your patients
Simple all-in-one wearable for easy application4
60% smaller¶ for comfortable, discreet wear
the most covered CGM brand13
For affordable care without compromising quality for the broadest audience of people with diabetes
Over one half of patients with commercial insurance have a $0 copay**,13
The majority of patients pay $0 for Dexcom G7 compared to $80 or greater for Libre. **,13
our CGM portfolio can help patients with all types of diabetes gain greater glucose control5-9
The Dexcom CGM portfolio is an expanding line of CGM systems that support a broad range of people with diabetes. Now you can simply prescribe the powerful CGM system that works best for your patients’ individual needs.
Dexcom G7
the most accurate CGM system1
An intuitive user experience with the advanced accuracy that only Dexcom offers
Dexcom G6
the most connected CGM system13
Industry-leading connectivity with pumps and pens for powerful integrated diabetes control
Dexcom G6 integrates with 80+ connected partners for seamless diabetes management
As the first Class II integrated CGM (iCGM) system authorized by the FDA, Dexcom works with a range of connected insulin pens and automated insulin delivery (AID) system partners. We continue to pursue collaboration opportunities with product and digital health brands, offering a multifaceted approach to effective diabetes management for patients, caregivers, and healthcare providers.
clinical resources to support you
DIaMonD Study 1 shows that Dexcom CGM use improves glucose control in adults with type 1 diabetes using insulin injections.
This resource is a brief, illustrated slide deck on setting up and using the Dexcom G7 Continuous Glucose Monitoring (CGM) System with the G7 App and the user’s personal compatible mobile device. The...
Smart device sold separately. For a list of compatible devices, visit dexcom.com/compatibility. †Compatible smartphone is required to pair a new Dexcom G7 sensor with a compatible Apple Watch. To use Share/Follow the smartphone must be within 33 feet of the Dexcom G7.‡Automated activity activity and medication logging available in Dexcom G7 app only. §Upgraded Bluetooth has a 33 ft bluetooth range, 13 feet farther than the previous 20 ft range. ¶Compared to a prior generation Dexcom CGM System. #Refers to estimated out-of-pocket cost for eligible commercially insured patients from the Dexcom CGM System sensor when claims are adjudicated as a pharmacy benefit, and includes benefits and offerings through available Dexcom programs, such as the voucher program. Actual cost may vary and is subject to individual insurance coverage. **For those with commercial pharmacy coverage. Individual costs may vary and is subject to individual insurance coverage.
1 Dexcom, data on file, 2023. 2 dQ&A US Diabetes Connections Patient Panel Report, Q1 2023. 3 Seagrove HCP Survey Q2 2022. 4 Dexcom G7 CGM System User Guide. 2024. 5 Beck RW, et al. JAMA. 2017;317(4):371-378. 6 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374. 7 Martens T, et al. JAMA. 2021;325(22):2262-2272. 8 Laffel LM, et al. JAMA. 2020;323(23):2388-2396. 9 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-7. 10 FreeStyle Libre 3 Quick Start Guide. Abbott Diabetes Care Inc.;2022. 11 Gilbert TR, et al. Diabetes Technol Ther. 2021;23(S1):S35-S39. 12 Nemlekar P, et al. Therapy. Diabetes Ther. 2024;15(3):639-48. 13 Dexcom, data on file, 2024.